IsoPlexis' precision development and pathway monitoring are advancing targeting in Oncology

Discover sources of resistance to Cancer Signaling Pathway therapies by understanding single-cell pathways that translate to therapeutic insights

IsoPlexis detects the key intracellular pathways in tumor cells that can uncover critical and unseen targets in oncology, helping you understand earlier in development the impacts of your therapies, and also mechanisms behind patient resistance in oncology research.

Featured Webinar
Cancer Resistance Revealed Through the Single Cell Intracellular Proteome, Masked Through Bulk and Genomics
featured webinars & interviews
See how industry leaders and pioneers are revealing the true functional biology to accelerate research and medicine
Proteomics Webinars
Understand the Structure and Functions of the p53 Pathway
Arnold Levine, PhD, Professor Emeritus, Simons Center for Systems Biology, Institute for Advanced Study
Proteomics Webinars
Learn how Cancer Cell Communication can Infer a Strategy to Inhibit Tumor Cell Migration
Denis Wirtz, PhD, Vice Provost for Research Director, Johns Hopkins Physical Sciences-Oncology Center Johns Hopkins University and Johns Hopkins School of Medicine
Proteomics Webinars
Learn to reveal cancer resistance through single-cell intracellular proteome
Rui Zheng, PhD, VP of Innovations, IsoPlexis
Automate Your Entire Workflow With One System
ONE INSTRUMENT & Workflow Step
The IsoLight
Data visualization software
Proteomic Barcoded Chips
IsoCode & CodePlex